We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Racial and ethnic disparities in treatment with the addiction medication buprenorphine increased between 2006 and 2020, according to a new study. Black and Hispanic patients received treatment for less time than white patients.
View our curated digest of the latest research news, including a study examining the disruptions to U.S. local public health's role in population-based substance use prevention and response during COVID-19.
Legislators and policymakers on the local, state and federal levels should use opioid settlement funds for substantial allocations to prevention initiatives, as well as immediate funding for evidence-based treatment, recovery support and overdose reversals, advocates urge in STAT.
A new study provides evidence that administering buprenorphine within 10 minutes after an overdose patient wakes up results in a substantial number of patients seeking addiction treatment within 30 days, Stateline reports.
View our curated digest of the latest research news, including a nationwide study on health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in federally qualified health centers and other primary care settings.